AVEO PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$2.17M, a 76.5% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$24.5M, a 56.3% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$49.6M, a 27.5% decline from 2020.
  • Aveo Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$38.9M, a 10295% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Operating Income (Loss) for 2019 was -$374K, a 98.5% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$24.5M -$2.17M +$7.05M +76.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$31.5M -$7.15M +$7.91M +52.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$39.5M -$9.01M +$10.1M +52.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$49.6M -$6.16M +$6.54M +51.5% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 -$56.1M -$9.22M -$1.16M -14.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$54.9M -$15.1M -$7.66M -103% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$47.3M -$19.1M -$8.4M -78.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$38.9M -$12.7M -$6.06M -91.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$32.8M -$8.06M -$26.9M -143% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 -$5.91M -$7.41M -$2.51M -51.3% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 -$3.39M -$10.7M -$3.02M -39.2% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 -$374K -$6.63M -$291K -4.59% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$83K $18.9M +$24.3M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-16
Q2 2019 -$24.3M -$4.89M +$1.68M +25.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-16
Q1 2019 -$26M -$7.7M -$666K -9.47% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-16
Q4 2018 -$25.4M -$6.34M +$3.73M +37% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$29.1M -$5.41M -$3.26M -151% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$25.8M -$6.57M +$2.26M +25.6% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$28.1M -$7.03M +$725K +9.35% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$28.8M -$10.1M -$645K -6.84% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$28.2M -$2.15M +$3.44M +61.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$31.6M -$8.83M -$1.69M -23.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$29.9M -$7.76M -$523K -7.23% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$29.4M -$9.43M -$3.3M -53.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$26.1M -$5.59M -$14.1M -166% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$12M -$7.14M -$2.52M -54.6% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$9.51M -$7.23M +$2.92M +28.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$12.4M -$6.12M +$6.87M +52.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 -$19.3M $8.47M +$22.6M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-22
Q2 2015 -$41.9M -$4.62M +$12.8M +73.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-22
Q1 2015 -$54.7M -$10.1M -$4.26M -72.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-22
Q4 2014 -$50.4M -$13M +$3.08M +19.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$53.5M -$14.1M +$9.51M +40.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$63M -$17.5M +$13.6M +43.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$76.6M -$5.89M +$27.3M +82.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$104M -$16.1M +$4.53M +22% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-06
Q3 2013 -$108M -$23.6M +$5.77M +19.6% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-06
Q2 2013 -$114M -$31.1M -$2.31M -8.04% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-06
Q1 2013 -$112M -$33.2M -$256K -0.78% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-06
Q4 2012 -$112M -$20.6M +$3.83M +15.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-13
Q3 2012 -$115M -$29.4M -$6.29M -27.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-13
Q2 2012 -$109M -$28.8M -$23.9M -488% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 -$85.3M -$32.9M -$119M -138% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
Q4 2011 $33.9M -$24.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 -$23.1M -$5.45M -30.9% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-11
Q2 2011 -$4.9M +$9.32M +65.6% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-11
Q1 2011 $86.4M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-11
Q3 2010 -$17.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$14.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.